Atara Biotherapeutics
World Rank (Jan-05-2024)
25,337
Market Cap (Jan-05-2024)
0.046 Billion USD
World Rank (Jul-30-2023)
17,991
Market Cap (Jul-30-2023)
0.202 Billion USD
World Rank (Dec-25-2022)
16,070
Market Cap (Dec-25-2022)
0.284 Billion USD
World Rank (Jan-07-2022)
7,703
Market Cap (Jan-07-2022)
1.41 Billion USD
Annual Revenue in USD
20 Million USD
Annual Net Income in USD
-340 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
Atara Biotherapeutics is a off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. It is estimated that the annual revenue is currently $36M per year and has 450 Employees as on 2019. The headquarters is in USA.
Company Website